We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01296932
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : August 17, 2017
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 30, 2017
  Study Completion Date : May 30, 2017